ShareValue.ai

ShareValue scores for PRCT: Valuation 46, Quality 52, Growth 66, Health 41.

Procept Biorobotics Corp logo

PRCT
NASDAQ

Procept Biorobotics Corp

$22.56(+4.98%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

7% to 17%
Valuation
46
Fair Value
Price vs Value
Quality
52
Moderate
Business Strength
Growth
66
Moderate
Revenue & Earnings
Health
41
Moderate
Financial Stability
Momentum
64
Bullish
Price Trend

Company Details

About

PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

Score Analysis

AI Investment Thesis

Data as of:Jun 29, 2026
|
Last calculated:Jun 29, 2026